• Integrated Kidney Care of Michigan, LLC

    KCE Located In: Michigan

    • Integrated Kidney Care of Michigan, LLC

    KCE Located In: Michigan

Participant Groups and Providers

XIAOPING HUANG MD PHD PC

XIAOPING HUANG

RENAL ASSOCIATES OF MID-MICHIGAN PC

ADEEL KHAN

JENNA MCCUMMINGS

KENDA PARKER

MOHAN KRISHNA BANGARU

GRATIOT-ISABELLA NEPHROLOGY PC

JOSE FUENTE

ASCENSION ST JOHN

DARLA GRANGER

DIALYSIS AND NEPHROLOGY CONSULTANTS PC

AMANDA GOMES

CARLOS MARCHENA

DAVID BUTCHER

SHREEDHAR ADHIKARI

WEST MICHIGAN NEPHROLOGY PLLC

EMILY CONLEY

GREGORY DOWNER

JAMES CONLEY

JOSEPH MCKENNA

MARK STANIFORTH

RANDALL MUIR

NEPHROLOGY HYPERTENSION CLINIC PC

CHILAKAPATI KUMAR

FADI ABUHMAID

JEFFREY GUTMAN

KRISTIN GLAAB-CHANDY

NAUSHAD PERVEZ

PINNAMANENI PRASAD

SUDHEER UMMADI

VIJAYAKUMAR PARAMASIVAM

COMORIN KIDNEYCARE PLLC

SOPHIA ARUNSELVAN

RENAL CARE CONSULTANT PC

SHAZIA RAZA

Preferred Groups and Providers

VILLAGEHEALTH DM LLC

Governing Body Designees

Sophia Arunslevan
Comorin Kidneycare

Carlos Marchena
Dialysis and Nephrology Consultants

Jose Fuente
Gratiot Isabella Nephrology

Sudheer Ummadi
Nephrology Hypertension Clinic, P.C. (Dearborn)

Adeel Khan
Renal Associates of Mid Michigan

Dr. Shazia Raza
Renal Care Consultant, PC

Mark Staniforth
West Michigan Nephrology

Xiaoping Huang
Xiaoping Huang MD

Mary Wozniak
Consumer Advocate

Brent Habitz
Davita IKC

Jaren Crane
Davita IKC

Clinical and Administrative Leadership

Jaren Crane
Primary Contact & Administrative Leader
Director, DaVita IKC

Sudheer Ummadi
KCE Clinical Leader
Nephrology Hypertension Clinic, P.C. (Dearborn)

Quality Measures

Information for the following performance measures will be available by February 1st, 2024.

  • The Depression Response measure is a patient-reported outcome measure that assesses the percentage of adult patients (18 years of age or older) who score >9 on the Patient Health Questionnaire (PHQ-9), have a diagnosis of major depression or dysthymia and who demonstrate a response to treatment at approximately 12 months.
  • The Patient Activation Measure (PAM) licensed through Insignia Health (a Phreesia company), assesses the attitudes, motivators, and behaviors that allow a patient to manage his or her healthcare issues. Patient activation is essential to achieving improved health outcomes and cost control.
  • Optimal ESRD Starts quantifies the ability of healthcare providers to prepare patients for ESRD by educating them and their families about the need for dialysis or kidney transplant, helping them to make appropriate and informed choices about their treatment modality, and supporting them in successfully transitioning to dialysis or kidney transplantation as kidney function declines.

Shared Savings and Losses

Information for the following performance measures will be available by February 1st, 2024.

  • Total amount of Shared Savings or Shared Losses per Performance Year
  • Proportion of Shared Savings invested in the program and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries
  • Proportion of Shared Savings to KCE Participants and Preferred Providers for each Performance Year

For a full list of facilities and joint ventures, please click here.

For more information on CKCC, click here.